Increased adherence eight months after switch from twice daily calcineurin inhibitor based treatment to once daily modified released tacrolimus in heart transplantation

BACKGROUND: Modified-release tacrolimus (TAC) is a new, once-daily oral formulation of the established immunosuppressive agent TAC. This study evaluated long-term patient adherence, as well as safety and efficacy, in stable patients after heart transplantation (HTx) who switched from a conventional...

Descripción completa

Detalles Bibliográficos
Autores principales: Doesch, Andreas O, Mueller, Susanne, Akyol, Ceylan, Erbel, Christian, Frankenstein, Lutz, Ruhparwar, Arjang, Ehlermann, Philipp, Dengler, Thomas J, Katus, Hugo A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3808207/
https://www.ncbi.nlm.nih.gov/pubmed/24174870
http://dx.doi.org/10.2147/DDDT.S52820

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3808207/
https://www.ncbi.nlm.nih.gov/pubmed/24174870
http://dx.doi.org/10.2147/DDDT.S52820

Ejemplares similares